Literature DB >> 25712869

Aptamer-based sensing of β-casomorphin-7.

Abhishek Parashar1, Yudhishthir S Rajput1, Rajan Sharma2.   

Abstract

β-Casomorphin-7 (BCM-7), a seven amino acid peptide, is released during digestion of β-casein A1 variant of milk which is speculated to be associated with certain diseases. Fifteen ssDNA aptamers having high affinity toward BCM-7 were identified from a 72 nt long random library after ten rounds of systematic evolution of ligands by exponential enrichment. Dissociation constant values of selected aptamers were in the range of 7.7-156.7 nM. Seq6 aptamer exhibited the lowest Kd value. Nine aptamers were evaluated for their binding toward BCM-7, BCM-9A1, and BCM-9A2 peptides, and binding was variable. SeqU5 exhibited the lowest binding with BCM-9A1 and BCM-9A2. Aptamer-coated gold nanoparticles (GNPs) resulted in color change of GNPs in the presence of BCM-7, thereby establishing recognition of BCM-7 by aptamers. The enzyme-linked aptamer-sorbent assay (ELASA) was evaluated as an assay of BCM-7 in biological fluids. BCM-7-peroxidase competed with BCM-7 in ELASA, performed with BCM-7 solution and BCM-7 spiked urine pretreated with urease, plasma, and β-casein digest samples.

Entities:  

Keywords:  ELASA; SELEX; aptamer; gold nanoparticles; β-casein; β-casomorphin-7

Mesh:

Substances:

Year:  2015        PMID: 25712869     DOI: 10.1021/acs.jafc.5b00007

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  3 in total

Review 1.  Aptamers in HIV research diagnosis and therapy.

Authors:  Jyoti Bala; Srinivasan Chinnapaiyan; Rajib Kumar Dutta; Hoshang Unwalla
Journal:  RNA Biol       Date:  2018-02-12       Impact factor: 4.652

Review 2.  Aptamers in Therapeutics.

Authors:  Abhishek Parashar
Journal:  J Clin Diagn Res       Date:  2016-06-01

3.  Immobilized aptamer on gold electrode senses trace amount of aflatoxin M1.

Authors:  Amit Kumar Pandey; Yudhishthir Singh Rajput; Rajan Sharma; Dheer Singh
Journal:  Appl Nanosci       Date:  2017-11-13       Impact factor: 3.674

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.